Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
- V. Kaasinen, H. Vilkman, J. Hietala, K. Någren, J. Rinne
- Psychology, Medicine
- Neurobiology of Aging
- 1 September 2000
Loss of dopamine D2-like receptors in the striatum has been associated with both normal human aging and impairment of cognitive and motor functions in the elderly. To investigate whether there are… Expand
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
- J. Hietala, E. Syvälahti, H. Vilkman, K. Vuorio, R. Salokangas
- Psychology, Medicine
- Schizophrenia Research
- 4 January 1999
We have previously reported aberrations in the striatal presynaptic dopamine function in neuroleptic-naive schizophrenic patients compared to healthy controls (Hietala, J., Syvälahti, E., Vuorio, K.… Expand
Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride
- J. Hirvonen, S. Aalto, +6 authors J. Hietala
- Chemistry, Medicine
- Nuclear medicine communications
- 1 December 2003
11C-Raclopride is a widely used positron emission tomography (PET) tracer for measurement of striatal D2 dopamine receptor binding characteristics. Recently, 11C-raclopride has also been used for… Expand
Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.
- A. Laakso, H. Vilkman, +7 authors J. Hietala
- Medicine
- The American journal of psychiatry
- 1 February 2000
OBJECTIVE
Recent in vivo imaging studies indicate a dysregulated presynaptic function of the striatal dopaminergic system in patients with schizophrenia. To further explore the basis of this… Expand
High levels of dopamine activity in the basal ganglia of cigarette smokers.
- R. Salokangas, H. Vilkman, +7 authors J. Hietala
- Psychology, Medicine
- The American journal of psychiatry
- 1 April 2000
OBJECTIVE
The authors' goal was to study presynaptic dopamine activity in smoking and nonsmoking human subjects in vivo.
METHOD
[(18)F]Fluorodopa ([(18)F]DOPA) uptake K(i) values in the basal… Expand
Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease
- V. Kaasinen, K. Någren, +5 authors J. Rinne
- Psychology, Medicine
- Neurology
- 11 April 2000
Objective: To investigate whether dopamine D2 and D3 receptor subtypes (D2/3Rs) outside the caudate-putamen are affected in PD. Background: Alterations in striatal D2-like dopamine receptors in PD… Expand
Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man
- S. Aalto, J. Ihalainen, +8 authors J. Hietala
- Psychology, Medicine
- Psychopharmacology
- 7 July 2005
RationaleThe noncompetitive glutamate N-methyl-d-aspartate receptor antagonist ketamine induces transient psychotic symptoms in man. Involvement of dopaminergic mechanisms in these effects has been… Expand
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects
- A. Laakso, H. Vilkman, J. Bergman, M. Haaparanta, J. Hietala
- Psychology, Medicine
- Biological Psychiatry
- 1 October 2002
BACKGROUND
There are sex differences in the clinical features of several neuropsychiatric illnesses associated with dopamine dysfunction. The effects of sex on brain dopaminergic function have been… Expand
Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography
- J. Tiihonen, H. Vilkman, +10 authors J. Hietala
- Psychology, Medicine
- Molecular Psychiatry
- 1 March 1998
Recent in vivo studies have shown low dopamine D2 receptor and dopamine transporter densities among late onset (type 1) alcoholics. We have now studied 6-[18F]-FDOPA (FDOPA) uptake in 10 type 1… Expand
Ketamine does not decrease striatal dopamine D2 receptor binding in man
- S. Aalto, J. Hirvonen, +6 authors J. Hietala
- Chemistry, Medicine
- Psychopharmacology
- 12 October 2002
Abstract
Rationale. A glutamate–dopamine interaction has been implicated in the psychosis-like effects of glutamate N-methyl-D-aspartate (NMDA) receptor antagonists, such as phencyclidine and… Expand